Methylmercury inhibits type II 5′-deiodinase activity in NB41A3 neuroblastoma cells
- 20 February 2006
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 161 (2) , 96-101
- https://doi.org/10.1016/j.toxlet.2005.08.001
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine SelenodeiodinasesEndocrine Reviews, 2002
- Mercuric Ion Attenuates Nuclear Factor-κB Activation and DNA Binding in Normal Rat Kidney Epithelial Cells: Implications for Mercury-Induced NephrotoxicityToxicology and Applied Pharmacology, 2001
- Neurotoxicity and molecular effects of methylmercuryBrain Research Bulletin, 2001
- Thyroid Hormone Regulates the Extracellular Organization of Laminin on AstrocytesEndocrinology, 1999
- Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues.Journal of Clinical Investigation, 1996
- Cyclic adenosine 3′,5′-monophosphate and glucose stimulate thyroxine 5′-deiodinase type II in cultured mouse neuroblastoma cellsMetabolism, 1990
- The effects of methylmercury on the developing brainProgress in Neurobiology, 1989
- An Analysis of the Sources and Quantity of 3,5,3′-Triiodothyronine Specifically Bound to Nuclear Receptors in Rat Cerebral Cortex and Cerebellum*Endocrinology, 1982
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A PHYSICOCHEMICAL RATIONALE FOR THE BIOLOGICAL ACTIVITY OF MERCURY AND ITS COMPOUNDSAnnals of the New York Academy of Sciences, 1957